Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
DaVita HealthCare Partner
(NY:
DVA
)
193.31
UNCHANGED
Delayed Quote
Updated: 7:00 PM EDT, Oct 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DaVita HealthCare Partner
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Key Takeaways From DaVita Analyst Ratings
↗
August 08, 2024
Via
Benzinga
DaVita (DVA) Q2 2024 Earnings Call Transcript
↗
August 06, 2024
DVA earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
DVA Stock Earnings: DaVita Beats EPS, Beats Revenue for Q2 2024
↗
August 06, 2024
DVA stock results show that DaVita beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Financial Crime Weekly: DaVita Agrees To Pay $34.5M For Kickbacks, Hospice Provider Doles Out $19.4M For False Claims
↗
July 19, 2024
DaVita Inc., a kidney dialysis provider, will pay $34.5 million for allegedly paying kickbacks to competitors and doctors for patient referrals.
Via
Benzinga
2 Warren Buffett Stocks to Buy Hand Over Fist and 1 to Avoid
↗
June 15, 2024
As the late Meatloaf once sang, "Two out of three ain't bad."
Via
The Motley Fool
Buffett Buys on a Budget: The 3 Cheapest Stocks Held by Berkshire Hathaway
↗
June 11, 2024
You can't go wrong by following in the Oracle's footsteps and buying these cheap Buffett stocks before the market catches on.
Via
InvestorPlace
6 Analysts Assess DaVita: What You Need To Know
↗
May 06, 2024
Via
Benzinga
DaVita Inc. (NYSE: DVA) Making Surprising Moves in Tuesday Session
March 05, 2024
Via
Investor Brand Network
These Warren Buffett Stocks Are Trouncing the S&P 500 so Far This Year. Are They Still Buys?
↗
June 07, 2024
Buffett no doubt likes what he's seeing with these high-flying stocks.
Via
The Motley Fool
Topics
Stocks
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
↗
May 17, 2024
Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent deconsolidation. Despite holding a 32% stake, challenges like high dialysis patient mortality and...
Via
Benzinga
Tandem Diabetes Catapults Above A Profit-Taking Zone, But DaVita Reverses, Nearly Triggering A Sell Signal
↗
May 03, 2024
Tandem Diabetes stock surged above a profit-taking zone on Friday, but DaVita reversed course and tumbled at the open.
Via
Investor's Business Daily
The Big Split: 3 Stock Spinoffs Are Coming. Should You Buy?
↗
May 03, 2024
Stock spinoffs can unlock shareholder value but management sometimes uses them to get rid of unwanted, slow-growing businesses.
Via
InvestorPlace
DaVita (DVA) Q1 2024 Earnings Call Transcript
↗
May 02, 2024
DVA earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
DaVita Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
↗
February 20, 2024
Via
Benzinga
DVA Stock Earnings: DaVita Beats EPS, Beats Revenue for Q1 2024
↗
May 02, 2024
DVA stock results show that DaVita beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
3 Healthcare Stocks With the Potential to Triple Your Investment by 2026
↗
May 01, 2024
Learn how these three healthcare stocks offer sharp opportunities in pharmaceuticals, healthcare services, and biotechnology.
Via
InvestorPlace
Warren Buffett's 3 Best-Performing Stocks So Far in 2024: Are They Buys Now?
↗
April 27, 2024
These high-flying Buffett stocks could be attractive to different kinds of investors.
Via
The Motley Fool
Ford, Nvidia Among Top S&P 500 Stocks Monday; Tesla Extends Losses
↗
April 22, 2024
Ford, United Airlines and megacap AI stock Nvidia were big-cap winners.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Stocks
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
↗
April 18, 2024
ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use.
Via
Investor's Business Daily
The Best Warren Buffett Stocks to Buy With $300 Right Now
↗
April 11, 2024
Even with $300, many Buffett investments are within reach of the average investor.
Via
The Motley Fool
3 Soaring, Highly-Ranked Value Stocks To Buy In April
↗
April 06, 2024
The stock market bounced back on Wednesday and looked strong through morning trading Thursday until sellers showed up.
Via
Talk Markets
3 High-Dividend ETFs That Could Be Smart Investments Right Now
↗
April 04, 2024
These are three great ways to get income in your portfolio without the hard work of choosing stocks and bonds on your own.
Via
The Motley Fool
Topics
Bonds
ETFs
Warren Buffett's Berkshire Hathaway Owns Over 25% of These 4 Companies (Hint: Apple Isn't One of Them)
↗
March 24, 2024
Berkshire even lists one of these companies as a subsidiary.
Via
The Motley Fool
3 No-Brainer Warren Buffett Stocks to Buy Right Now
↗
March 19, 2024
Strong brands and market presence make these three companies attractive investments.
Via
The Motley Fool
Why Are Dialysis Provider Stocks Trading Higher On Tuesday?
↗
March 05, 2024
Novo Nordisk's FLOW trial reveals a 24% reduction in kidney disease progression, cardiovascular events, and death with semaglutide 1.0 mg compared to placebo. Impact on dialysis stocks
Via
Benzinga
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
March 05, 2024
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.
Via
Benzinga
NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday
↗
March 05, 2024
U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday.
Via
Benzinga
Topics
Stocks
Why Dialysis Stocks DaVita, Fresenius Soared On Novo's Ozempic News
↗
March 05, 2024
Novo Nordisk tested its diabetes and weight-loss drug in patients with chronic kidney disease.
Via
Investor's Business Daily
3 Cheap Stocks to Buy Now for Fast Gains
↗
February 22, 2024
Dive into the world of investing with cheap stocks DaVita, Altria, and StoneCo as they show potential growth.
Via
InvestorPlace
Dialysis Player Fresenius Medical's Q4 Sales Hold Steady: Details
↗
February 20, 2024
Fresenius Medical Care Q4 2023 revenue: €4.9 billion. Patient volume growth is expected at 0.5%-2% in 2024.
Via
Benzinga
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit